Copy number variation of HLA-DQA1 and APOBEC3A/3B contribute to the susceptibility of systemic sclerosis in the Chinese han population

Journal of Rheumatology

Volumn 43, Issue 5, 2016, Pages 880-886

  Guo, Shicheng ^a   Li, Yuan ^a   Wang, Yi ^a   Chu, Haiyan ^a   Chen, Yulin ^a   Liu, Qingmei ^a   Guo, Gang ^a   Tu, Wenzhen ^a   Wu, Wenyu ^a   Zou, Hejian ^a   Yang, Li ^a   Xiao, Rong ^a   Ma, Yanyun ^a   Zhang, Feng ^a   Xiong, Momiao ^a   Jin, Li ^a   Zhou, Xiaodong ^a   Wang, Jiucun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Case control studies; Copy number variation; Genetic predisposition to disease; HLA antigens; Systemic sclerosis

Indexed keywords

GENOMIC DNA; APOBEC3A PROTEIN, HUMAN; CYTIDINE DEAMINASE; HLA DQ ANTIGEN; HLA-DQA1 ANTIGEN; PROTEIN;

APOBEC3A GENE; APOBEC3B GENE; ARTICLE; CDC42EP3 GENE; CHINESE; CHROMOSOME 22Q; CHROMOSOME 6Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; GENE; GENE LOSS; GENETIC ASSOCIATION; GENETIC GAIN; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; HLA DQA1 GENE; HLA DRB5 GENE; HUMAN; IRGM GENE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC SCLEROSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; GENETIC PREDISPOSITION; GENETICS;

ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CYTIDINE DEAMINASE; DNA COPY NUMBER VARIATIONS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ ALPHA-CHAINS; HUMANS; PROTEINS; SCLERODERMA, SYSTEMIC;

EID: 84969194976     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.150945     Document Type: Article

References (41)

1. Bunn CC, Black CM. Systemic sclerosis: an autoantibody mosaic. Clin Exp Immunol 1999;117:207-8.
2. Tamby MC, Chanseaud Y, Guillevin L, Mouthon L. New insights into the pathogenesis of systemic sclerosis. Autoimmun Rev 2003;2:152-7.
3. Silman A, Jannini S, Symmons D, Bacon P. An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 1988;27:286-90.
4. Arias-Nuñez MC, Llorca J, Vazquez-Rodriguez TR, Gomez-Acebo I, Miranda-Filloy JA, Martin J, et al. Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study. Medicine 2008;87:272-80.
5. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-55.
6. Wang J, Assassi S, Guo G, Tu W, Wu W, Yang L, et al. Clinical and serological features of systemic sclerosis in a Chinese cohort. Clin Rheumatol 2013;32:617-21.
7. Arnett FC, Cho M, Chatterjee S, Aguilar MB, Reveille JD, Mayes MD. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum 2001;44:1359-62.
8. Feghali-Bostwick C, Medsger TA Jr, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 2003;48:1956-63.
9. Jüngel A, Distler JH, Gay S, Distler O. Epigenetic modifications: novel therapeutic strategies for systemic sclerosis? Expert Rev Clin Immunol 2011;7:475-80.
10. Martin JE, Broen JC, Carmona FD, Teruel M, Simeon CP, Vonk MC, et al. Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up. Hum Mol Genet 2012;21:2825-35.
11. Gorlova O, Martin JE, Rueda B, Koeleman BP, Ying J, Teruel M, et al. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet 2011;7:e1002178.
12. Allanore Y, Saad M, Dieude P, Avouac J, Distler JH, Amouyel P, et al. Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet 2011;7:e1002091.
13. López-Isac E, Bossini-Castillo L, Simeon CP, Egurbide MV, Alegre-Sancho JJ, Callejas JL, et al. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility. Arthritis Res Ther 2014;16:R6.
14. Sharif R, Mayes MD, Tan FK, Gorlova OY, Hummers LK, Shah AA, et al. IRF5 polymorphism predicts prognosis in patients with systemic sclerosis. Ann Rheum Dis 2012;71:1197-202.
15. Koumakis E, Wipff J, Dieude P, Ruiz B, Bouaziz M, Revillod L, et al. TGFβ receptor gene variants in systemic sclerosis-related pulmonary arterial hypertension: results from a multicentre EUSTAR study of European Caucasian patients. Ann Rheum Dis 2012;71:1900-3.
16. Bossini-Castillo L, Martin JE, Broen J, Simeon CP, Beretta L, Gorlova O Y, et al. Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study. Ann Rheum Dis 2013;72:602-7.
17. Yi L, Wang JC, Guo XJ, Gu YH, Tu WZ, Guo G, et al. STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population. Int J Immunopathol Pharmacol 2013;26:473-8.
18. Guo S, Wang YL, Li Y, Jin L, Xiong M, Ji QH, et al. Significant SNPs have limited prediction ability for thyroid cancer. Cancer Med 2014;3:731-5.
19. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461:747-53.
20. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007;315:848-53.
21. Wang J, Yang Y, Guo S, Chen Y, Yang C, Ji H, et al. Association between copy number variations of HLA-DQA1 and ankylosing spondylitis in the Chinese Han population. Genes Immun 2013;14:500-3.
22. McKinney C, Fanciulli M, Merriman ME, Phipps-Green A, Alizadeh BZ, Koeleman BP, et al. Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Ann Rheum Dis 2010;69:1711-6.
23. Thabet MM, Huizinga TW, Marques RB, Stoeken-Rijsbergen G, Bakker AM, Kurreeman FA, et al. Contribution of Fcgamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis. Ann Rheum Dis 2009;68:1775-80.
24. McKinney C, Merriman ME, Chapman PT, Gow PJ, Harrison AA, Highton J, et al. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Ann Rheum Dis 2008;67:409-13.
25. García-Ortiz H, Velázquez-Cruz R, Espinosa-Rosales F, Jiménez-Morales S, Baca V, Orozco L. Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population. Ann Rheum Dis 2010;69:1861-5.
26. Wu L, Guo S, Yang D, Ma Y, Ji H, Chen Y, et al. Copy number variations of HLA-DRB5 is associated with systemic lupus erythematosus risk in Chinese Han population. Acta Biochim Biophys Sin 2014;46:155-60.
27. McKinney C, Broen JC, Vonk MC, Beretta L, Hesselstrand R, Hunzelmann N, et al. Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis. Genes Immun 2012;13:458-60.
28. Du R, Lu C, Jiang Z, Li S, Ma R, An H, et al. Efficient typing of copy number variations in a segmental duplication-mediated rearrangement hotspot using multiplex competitive amplification. J Hum Genet 2012;57:545-51.
29. Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: Addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001;44:735-6.
30. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
31. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000; 43:2437-44.
32. Dessau RB, Pipper CB. ["R"-project for statistical computing]. [Article in Danish] Ugeskr Laeger 2008;170:328-30.
33. Kundu S, Aulchenko YS, van Duijn CM, Janssens AC. PredictABEL: an R package for the assessment of risk prediction models. Eur J Epidemiol 2011;26:261-4.
34. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011;12:77.
35. Lou H, Li S, Yang Y, Kang L, Zhang X, Jin W, et al. A map of copy number variations in Chinese populations. PLoS One 2011;6:e27341.
36. McLean-Tooke A, Spickett GP, Gennery AR. Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome. Scand J Immunol 2007;66:1-7.
37. Lambert NC, Distler O, Müller-Ladner U, Tylee TS, Furst DE, Nelson JL. HLA-DQA1∗0501 is associated with diffuse systemic sclerosis in Caucasian men. Arthritis Rheum 2000;43:2005-10.
38. Berger G, Durand S, Fargier G, Nguyen XN, Cordeil S, Bouaziz S, et al. APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathog 2011;7:e1002221.
39. Stenglein MD, Burns MB, Li M, Lengyel J, Harris RS. APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat Struct Mol Biol 2010;17:222-9.
40. Landry S, Narvaiza I, Linfesty DC, Weitzman MD. APOBEC3A can activate the DNA damage response and cause cell-cycle arrest. EMBO Rep 2011;12:444-50.
41. Bogerd HP, Wiegand HL, Doehle BP, Lueders KK, Cullen BR. APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res 2006;34:89-95.